(R)-2-((2-oxo-3,4-dihydroquinolin-1(2H)-yl)methyl)-6,8-dihydrospiro[cyclopenta[g]quinoline-7,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one

ID: ALA1090847

PubChem CID: 46885134

Max Phase: Preclinical

Molecular Formula: C28H22N4O2

Molecular Weight: 446.51

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1CCc2ccccc2N1Cc1ccc2cc3c(cc2n1)C[C@@]1(C3)C(=O)Nc2ncccc21

Standard InChI:  InChI=1S/C28H22N4O2/c33-25-10-8-17-4-1-2-6-24(17)32(25)16-21-9-7-18-12-19-14-28(15-20(19)13-23(18)30-21)22-5-3-11-29-26(22)31-27(28)34/h1-7,9,11-13H,8,10,14-16H2,(H,29,31,34)/t28-/m1/s1

Standard InChI Key:  GCWWLFCJNPWAEP-MUUNZHRXSA-N

Molfile:  

     RDKit          2D

 34 40  0  0  0  0  0  0  0  0999 V2000
    4.4364   -0.3334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6835    0.1527    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8834    0.3625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4157   -1.0611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4906    0.5915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1911    0.1438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1495   -0.6794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9194   -0.9733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9869    0.3584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5830    1.1333    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7229   -0.6115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7550    0.2070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3012   -0.6799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3911   -1.1268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2554    0.1396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1271   -0.7495    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1700    0.0758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9019    0.4534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5994    0.0081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8235   -1.2010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5568   -0.8172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2537   -1.2601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2185   -2.0869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4806   -2.4685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7868   -2.0234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4749    0.5244    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7310   -0.6731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9607   -0.9689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8330   -1.7824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4748   -2.3007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2466   -1.9999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3705   -1.1874    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0311   -1.0578    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9442    0.5880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 27  2  1  0
 12 34  1  0
  2  3  1  0
 34 15  2  0
 15 13  1  0
  1  3  1  1
 14 16  1  0
 16 17  1  0
  1 28  1  0
  7  8  1  0
  8  1  1  0
 16 20  1  0
 17 18  1  0
 18 19  1  0
 19 21  1  0
  1  9  1  0
  9  6  1  0
 20 21  2  0
 11  4  2  0
 21 22  1  0
  3 10  2  0
 22 23  2  0
 11 12  1  0
 23 24  1  0
  4  7  1  0
 24 25  2  0
 25 20  1  0
 17 26  2  0
  6  5  1  0
  5 12  2  0
 27 28  2  0
 14 13  1  0
 28 29  1  0
  6  7  2  0
 29 30  2  0
 13 33  2  0
 30 31  1  0
 33 11  1  0
 31 32  2  0
 32 27  1  0
M  END

Associated Targets(Human)

CALCRL Tclin Calcitonin gene-related peptide type 1 receptor (1509 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 446.51Molecular Weight (Monoisotopic): 446.1743AlogP: 4.10#Rotatable Bonds: 2
Polar Surface Area: 75.19Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.75CX Basic pKa: 3.87CX LogP: 4.10CX LogD: 4.10
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.50Np Likeness Score: -0.49

References

1. Stump CA, Bell IM, Bednar RA, Fay JF, Gallicchio SN, Hershey JC, Jelley R, Kreatsoulas C, Moore EL, Mosser SD, Quigley AG, Roller SA, Salvatore CA, Sharik SS, Theberge CR, Zartman CB, Kane SA, Graham SL, Selnick HG, Vacca JP, Williams TM..  (2010)  Identification of potent, highly constrained CGRP receptor antagonists.,  20  (8): [PMID:20299218] [10.1016/j.bmcl.2010.02.086]

Source